Age-related macular degeneration is the leading cause of irreversible blindness in Americans over 60 years of age. In October 2001 The National Eye Institute (NEI), part of the Federal government's National Institutes of Health, completed a 10 year major clinical study called the Age-Related Eye Disease Study (AREDS). AREDS proved that a special formula of antioxidant vitamins plus zinc slowed the progression of Age-Related Macular Degeneration (AMD) by 25 percent. AREDS researches have also found that patients with the highest intake of Omega 3 fatty acids had a 50% lower risk of developing more severe macular degeneration. Viteyes Omega 3 provides high potency Omega 3 in a convenient 1 softgel per day. Each pill contains 1,000mg of Omega 3 Fatty Acids, 300mg eicosapentaenoic acid (EPA) and 200mg docosahexaenoic acid (DHA). Viteyes Omega comes in a 90 easy to swallow softgel (3 month supply) bottle. Viteyes Omega is not a replacement for Viteyes AREDS Formulas, but rather an excellent product to take with the other Viteyes formulations. To ensure and maintain the maximum level of purity and potency, Viteyes is formulated using only the highest quality ingredients. Viteyes is manufactured following the most strict Goods Manufacturing Practices (GMPs) and adhere to applicable United States Pharmacopeia (USP) guidelines. Recommended Use: One soft gel daily with a meal.
|
Viteyes Omega 3 - (3 month supply)
